e-learning
resources
Vienna 2009
Sunday, 13.09.2009
Respiratory infection caused by Pseudomonas aeruginosa
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Influence of bronchiectasis in COPD exacerbations caused by
pseudomonas aeruginosa
M. Sancho, M. Gallego, C. Montón, X. Pomares, D. Mariscal, E. Castañer, A. Marin (Sabadell, Spain)
Source:
Annual Congress 2009 - Respiratory infection caused by Pseudomonas aeruginosa
Session:
Respiratory infection caused by Pseudomonas aeruginosa
Session type:
Oral Presentation
Number:
1363
Disease area:
Airway diseases, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Sancho, M. Gallego, C. Montón, X. Pomares, D. Mariscal, E. Castañer, A. Marin (Sabadell, Spain). Influence of bronchiectasis in COPD exacerbations caused by
pseudomonas aeruginosa
. Eur Respir J 2009; 34: Suppl. 53, 1363
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Impact of bronchiectasis on duration of hospitalization in patients with exacerbations of COPD
Source: International Congress 2015 – Asthma and COPD: overlap and exacerbations
Year: 2015
The effect of bronchiectasis on asthma exacerbations
Source: Annual Congress 2012 - Inflammation in airway diseases: diagnosis and management
Year: 2012
Influence of N-acetylcysteine on chronic bronchitis or COPD exacerbations: a meta-analysis
Source: Eur Respir Rev 2015; 24: 451-461
Year: 2015
Influence of bronchiectasis in patients hospitalized due to acute exacerbation of COPD.
Source: International Congress 2017 – Towards personalised medicine in COPD: biological and clinical phenotypes
Year: 2017
Etiology of exacerbations in severe COPD patients with bronchial chronic colonization by pseudomonas
Source: Annual Congress 2013 –Difficult and rare respiratory infections
Year: 2013
Chronic obstructive pulmonary disease exacerbations: Impact of the GOLD stage or the presence of bronchiectasis on sputum microbiology
Source: Annual Congress 2013 –Research questions on how viruses affect the respiratory system
Year: 2013
Mechanism by which inhaled bronchodilators prevent exacerbations in chronic obstructive pulmonary disease
Source: Annual Congress 2013 –Asthma and COPD drugs: efficacy, safety and pharmacoeconomics
Year: 2013
Occurrence and impact of bronchiectasis in patients with COPD
Source: International Congress 2017 – Highlights on clinical problems in COPD
Year: 2017
Evaluation of COPD exacerbations using the EXACT-U
Source: Annual Congress 2010 - COPD exacerbation
Year: 2010
Impact of halotherapy on COPD exacerbations
Source: International Congress 2019 – COPD treatment: cohorts and real-world studies
Year: 2019
Influence of bronchodilators on pulmonary hypertension in patients with chronic obstructive pulmonary disease (COPD) and COPD concomitant with bronchial asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 521s
Year: 2004
Effects of pulmonary rehabilitation on exacerbation number and severity in people with chronic obstructive pulmonary disease (COPD)
Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases
Year: 2016
Frequency of COPD exacerbations and severity of COPD
Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations
Year: 2013
Impact of comorbidities on chronic obstructive pulmonary disease (COPD) exacerbations in Singapore
Source: International Congress 2015 – Clinical assessment in asthma and COPD
Year: 2015
Impact of exacerbations on COPD
Source: Eur Respir Rev 2009; 19: 113-118
Year: 2010
Defining the contribution of emphysema and chronic bronchitis in COPD patients
Source: Eur Respir J 2003; 22: Suppl. 45, 539s
Year: 2003
Effect of noninvasive ventilation on interleukin-8 in COPD exacerbation
Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench
Year: 2013
The bronchitic phenotype is associated with frequent exacerbations in COPD irrespective of chronic bacterial airway infection
Source: Annual Congress 2013 –Guidelines and exacerbations
Year: 2013
Effect of lower airway bacterial colonisation on time to acute exacerbation in patients with COPD
Source: International Congress 2015 – COPD: exacerbations, gas exchange and associated dysfunction
Year: 2015
Management of COPD exacerbations
Source: ERS Lung Science Conference 2019
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept